US CDC leader appointed
This article was originally published in Scrip
US President Barack Obama has appointed Dr Thomas Frieden director of the Centers for Disease Control and Prevention (CDC). He has served as New York City's health commissioner since 2002 and will start in his new post in early June. Dr Richard Besser, who has served as acting CDC director during the H1N1 influenza outbreak, will return to his previous post as head of the CDC's co-ordinating office for terrorism preparedness and emergency response. Dr Frieden is the second former New York City health commissioner tapped to lead a public health agency under the Obama administration. Dr Margaret Hamburg, the nominee for FDA commissioner, led the New York City department from 1991 to 1997. The Senate health committee recently cleared Dr Hamburg's nomination, which now heads to the Senate floor for approval.
You may also be interested in...
Agency wants to ensure patients ‘aren’t unnecessarily or unfairly scared off or intimidated’ from taking biosimilars, Office of Therapeutic Biologics and Biosimilars' acting policy director Eva Temkin tells the FDA/CMS Summit; Temkin says recent guidance on biosimilar insulins shows agency is trying to be flexible on interchangeability data requirements.
AstraZeneca and Merck seek to add a pancreatic cancer indication for olaparib, while Merck has hopes of broadening pembrolizumab’s use in bladder cancer; two-day Oncologic Drugs Advisory Committee meeting also will include reviews of Celgene’s luspatercept in myelodysplastic syndromes-related anemia and Epizyme’s tazemetostat for epithelioid sarcoma.
Clinicians and sponsors want the US FDA to open up antibacterial labeling to include more data on efficacy against resistant pathogens and in other body sites, but regulatory restrictions may require a workaround in the form of rapid, peer-to-peer communications about the data on new products.